The Patent Finder

Novel Compounds and Uses Thereof

Kala Bio, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application 14/894,214, filed Nov 25, 2015. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 10,351,570Novel Compounds and Uses Thereof
In force
 · High confidence
Kala Bio, Inc.In force
High confidence
US 10,544,151Novel Compounds and Uses Thereof
In force
 · High confidence
Kala Bio, Inc.In force
High confidence
US 10,954,244Novel Compounds and Uses Thereof
Lapsed Mar 23, 2025 on the fee record
High confidence
Kala Bio, Inc.Lapsed Mar 23, 2025 on the fee record
High confidence
US 9,988,386Compounds for Treatment of Diseases of Abnormal Angiogenesis or Aberrant Growth Factors and Uses Thereof
Lapsed Jun 5, 2026 on the fee record
High confidence
Kala Bio, Inc.Lapsed Jun 5, 2026 on the fee record
High confidence
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Kala Bio, Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited